approval
saveRIFATER (ISONIAZID) — FDA approval
community read0 votes
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalRIFATER (ISONIAZID) — FDA approvalDec 5, 2025 · 344d ago
- approvalRIFATER (ISONIAZID) — FDA approvalFeb 5, 2025 · 647d ago
- approvalRIFATER (ISONIAZID) — FDA approvalOct 10, 2024 · 765d ago
- approvalRIFATER (ISONIAZID) — FDA approvalDec 8, 2023 · 1072d ago
- approvalRIFATER (ISONIAZID) — FDA approvalAug 16, 2023 · 1186d ago
- approvalRIFATER (ISONIAZID) — FDA approvalFeb 10, 2023 · 1373d ago
- approvalRIFATER (ISONIAZID) — FDA approvalJan 29, 2022 · 1750d ago
- approvalRIFATER (ISONIAZID) — FDA approvalOct 21, 2021 · 1850d ago
same company · ±60 days · 5
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalOct 8, 2025
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalOct 8, 2025
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalDec 5, 2025
- approvalRIFATER: RIFATER (ISONIAZID) — FDA approvalDec 5, 2025
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalDec 5, 2025
comments(0)
5-min edit window · permanent after that